Royalty Report: Medical, Device, Diagnostic – Collection: 246038

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 8

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 8

Primary Industries

  • Medical
  • Device
  • Diagnostic
  • Scientific & Technical Instruments
  • Cancer
  • Dental
  • Disease
  • Surgical
  • Laser

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 246038

License Grant
The Chinese Licensee has the exclusive right to manufacture the CTLM® in China and sell the CTLM® in China, Hong Kong, Macau and Taiwan. the CTLM® is a  CT Laser Mammography system, that uses computed tomography and laser techniques designed to detect breast abnormalities.
License Property
CTLM® stands for Computed Tomography Laser Mammography and is a method of visualizing the blood distribution within the breast. The CTLM® system is a CT-like scanner, its energy source for imaging is a laser beam and not ionizing radiation such as is found in conventional x-ray mammography or CT scanners.
Field of Use
The agreement pertains to diagnostic imaging.

IPSCIO Record ID: 27509

License Grant
The Company’s Chief Executive Officer grants to Licensee  the exclusive right to modify, customize, maintain, incorporate, manufacture, sell, and otherwise utilize and practice the above stated Patent, all improvements thereto and all technology related to the process, throughout the world. This license shall apply to any extension or re-issue of the Patent.
License Property
The CTLM employs a high-speed pico-second pulsed titanium sapphire laser and proprietary scanning geometry and reconstruction algorithms to detect and analyze masses in the breast indicia of malignancy or benignancy.  A device for detecting breast cancer through the skin in a non-invasive and objective procedure.

Patent number 5,692,511, issued on December 2, 1987

Field of Use
Licensee is a medical technology company that has developed a Computed Tomography Laser Mammography (system for detecting breast cancer through the skin in a non-invasive and objective procedure, which incorporates the use of the Patent (the CTLM).

IPSCIO Record ID: 629

License Grant
The Licensor hereby grants a worldwide, exclusive subLicenseable, royalty-bearing License, under the Licensor's Intellectual Property and  right in any Joint IP, to develop and commercialize products. The Laser Imager for Lab Animals or “LILA” system products may be marketed solely for use in imaging of any animal, but expressly excluding all imaging of humans.  It has licensed its laser optical imaging technology for use in small animal imaging.
License Property
The intellectual property embodied in US patent 5,952,664 protects the optical CT imaging of fluorophores; US patents 6,150,649, 6,331,700, and 6,681,130 protect the measurement of the low light levels emitted by these fluorophores.

IPSCIO Record ID: 6021

License Grant
The University has granted the Licensee an exclusive license for patents and patent applications in the field of Optical Coherence Imaging technology for dental applications in humans and animals, in the United States. The Licensor also grants to Licensee the right to issue royalty-bearing subLicenses to third parties in the Field of Use.
License Property
United States Patents Granted

5,570,182 Method for Detection of Dental Caries and Periodontal Disease Usin Optical
6,179,611 Dental Optical Coherence Domain Reflectometry Explorer

Optical Coherence Tomography, or ‘OCT’, is a technique for obtaining sub-surface images of translucent or opaque materials at a resolution equivalent to a low-power microscope. It is effectively ‘optical ultrasound’, imaging reflections from within tissue to provide cross-sectional images.

Field of Use
The field of Optical Coherence Imaging technology for dental applications in humans and animals.

IPSCIO Record ID: 233446

License Grant
Licensor grants the exclusive, world-wide license under Licensor’s rights in the Licensed Patents to make, have made, use, market and/or sell Products designed and marketed solely for use in the Field of Use; with the right to grant sublicenses to Sublicensees.

Licensor grants the world-wide right to practice the Technology to make, have made, use, market and/or sell Products designed and marketed solely for use in the Field of Use.

License Property
The patents include Multiwavelength Laser Source, Method for Reshaping the Eye, and,  Method for Removing Cataractous Material.

The Product(s) shall mean any goods or services whose manufacture, use or sale in any country would, but for this Agreement, comprise an infringement, including contributory infringement, of one or more Valid Claims; and any goods or services incorporating, or the manufacture, use or sale of which utilizes the Technology.

The technology shall mean all information, manufacturing techniques, data, designs or concepts, whether or not such specific information, manufacturing techniques, data, designs or concepts are or become publicly known or available, developed by Licensor which relate to methods and apparatus for laser-assisted opthalmic surgical procedures.

Field of Use
Field of Use shall refer to use of ultrafast laser medical instruments for human health and human cosmetic applications.

IPSCIO Record ID: 6066

License Grant
The Licensee exclusively licensed a portfolio of seven patents from the University for diagnostic products used in the dental field.
License Property
Optical Coherence Tomography (OCT) is generally regarded as the 6th Imaging Modality and is a new, light-based system with characteristics that make it ideally suited to bio-medical diagnostic imaging applications.  OCT represents a major advancement in imaging in dentistry due its ability to provide detailed characterization of the dental microstructures, enabling the dentist to make earlier and more accurate diagnosis of oral disease including decay and periodontal disease.  The early detection of tooth decay facilitates the dentist to employ non- or minimally invasive techniques to treat or even reverse decay and periodontal disease.  Less invasive treatment enhances the patient experience and results in a higher level of professional service and patient care. The proprietary OCT Dental Imaging System(TM) will be used by dentists to obtain a real-time chairside evaluation of the oral tissues to aid in the early detction of decay, periodontal disease and microstructural deficiencies.

In general, Optical Coherence Tomography, or ‘OCT’, is a technique for obtaining sub-surface images of translucent or opaque materials at a resolution equivalent to a low-power microscope. It is effectively ‘optical ultrasound’, imaging reflections from within tissue to provide cross-sectional images.

Patent No.
5,570,182; 6,179,611; 6,385,358; 6,419,484; 6,451,009; 6,466,713, 6,522,407

Field of Use
The rights granted apply to the dental field.

IPSCIO Record ID: 27570

License Grant
Licensor, a wholly owned subsidiary of the Licensee, hereby grants and agrees to grant to Licensee a license, with the right to grant sublicenses, to use the Licensed Patent Rights, the Licensed Copyrights, the Licensed Technology, and the Licensed Trademarks, to make, have made, use and sell, during the term of this Agreement, Products employing the Licensed Intellectual Property.

The License Agreement grants the Licensee the exclusive right to distribute the BreastCare DTS™ in the United States, Canada and certain countries in Asia, including China. Rights granted include the right to grant sublicenses, to use the Licensed Patent Rights, the Licensed Copyrights, the Licensed Technology, and the Licensed Trademarks, to make, have made, use and sell, during the term of this Agreement, Products employing the Licensed Intellectual Property. The license granted is limited to the United States, Canada, Asia and, subject to Licensor’s Right of First Refusal, the Open Territory and is exclusive within the United States, Canada and Asia as to all parties including the Licensor and non-exclusive as to the Open Territory except to the extent that Licensor does not exercise its Right of First Refusal. The Licensor hereby grants to Licensee the exclusive right to use the trademarks as set forth within the Exclusive Territory, the non-exclusive right to use the trademarks as set forth in the Open Territory, subject to Licensor’s Right of First Refusal, and the non-exclusive right to use the trademarks set forth within the Exclusive Territory and, subject to Licensor’s Right of First Refusal, the Open Territory.

License Property
Licensor owns or controls certain proprietary rights, including, but not limited to, patents, trademarks, copyrights, United States Food and Drug Administration ('FDA') filings, clinical studies, data, techniques, trade secrets, contract rights, concepts and know-how, relating to a product referred to as BreastCare DTS™ referred to herein as the “Product.” The Product has been cleared by the FDA to be marketed as an adjunct to mammography and other procedures for the detection of breast disease, including breast cancer. Licensor also owns or controls or has contracted to obtain the benefits of certain apparatus and methods for making the Product.

The BreastCare DTSâ„¢ measures underlying breast tissue temperature and not skin surface temperature by retaining the emitted heat when BreastCareâ„¢ DTS is placed against the breast for 15 minutes. The averaged and recorded reading on the BreastCare DTSâ„¢ has taken into consideration that the temperature patterns of a woman's breasts are closely symmetrical. This method detects abnormalities by comparing the temperature differences in the corresponding areas of a woman's breasts.

The licensed technology includes the BreastCare DTSâ„¢.  It is patented, non-invasive and FDA-cleared as an adjunct to mammography and other established procedures for the detection of breast disease, including breast cancer. DTS stands for “Differential Temperature Sensor,” indicating the ability of the device to compare temperatures in one area of the breast with others in the same breast and the other breast. The BreastCare DTSâ„¢device consists of two mirror image, lightweight and disposable foam pads with three wafer-thin foil sensors on each pad. Each of the three segments on each pad contains 18 rows of heat-sensitive chemical dots. The device is easy to use and requires no electricity or probes. The test is completely non-invasive. The pads are easily placed on a woman’s breasts inside the bra for 15 minutes. The device measures the deep heat energy that is transferred to the surface of the skin. Each heat-sensitive dot is calibrated to record the temperature of the surface of the breast. The dots themselves change color from blue to pink when exposed to specific temperatures. The results are clearly displayed and can be immediately evaluated. The heat-sensitive dots have embedded memory, which allows the results to be read after each test is completed.

U.S. Patent 6,086,247 as well as all related applications and/or issued patents. Related applications includes any related foreign or U.S. issued or pending applications, continuation applications, continuation-in-part applications, divisional applications, reissue applications, and provisional application.
U.S. Patent 6135968 – Differential temperature measuring device and method; Prostate Screening Device.
RE 32,000
RE 4,624264
Patent 4651749

Trademarks
BreastCare DTSTM BreastAlertTM Differential Temperature Sensor

Field of Use
The grant provides the right to develop, manufacture and commercialize the Product and derivative products for, among other purposes, the detection of disease, including breast cancer.  The Products covered by the License shall include any temperature sensing product manufactured by or on behalf of the Licensor using the patented technology or improvements thereto.

IPSCIO Record ID: 6023

License Grant
The Licensor has granted the Licensee a non-exclusive worldwide license to use certain medical imaging technologies, known as Optical Coherence Tomography, or ‘OCT,’ in the field of general dentistry, excluding oral surgery and imaging through a microscope.
License Property
(a) Licensee’s Release of a Licensed Product;
(b) Licensee’s First Commercial Sale of a Licensed Product; or
(c) the second anniversary of the effective date.

Optical Coherence Tomography is a technique for obtaining sub-surface images of translucent or opaque materials at a resolution equivalent to a low-power microscope. It is effectively ‘optical ultrasound’, imaging reflections from within tissue to provide cross-sectional images.

There are many industrial, medical, and other applications where high resolution (generally less than 10 micrometer) images of, and measurements of distances, thicknesses, and optical properties of, a biological or other sample are required.

“Method And Apparatus For Optical Imaging With Means For Controlling The Longitudinal Range Of The Sample”  Issued US Patent 5,321,501, June 14, 1994. Filed 4/29/92. – A method and apparatus for performing optical imaging on a sample wherein longitudinal scanning or positioning in the sample is provided by either varying relative optical path lengths for an optical path leading to the sample and to a reference reflector, or by varying an optical characteristic of the output from an optical source applied to the apparatus. Transverse scanning in one or two dimensions is provided on the sample by providing controlled relative movement between the sample and a probe module in such direction and/or by steering optical radiation in the probe module to a selected transverse position. The probe module may be an external module or may be an endoscope or angioscope utilized for scanning internal channels. Multiple optical paths may be provided for parallel scanning and focus may be enhanced by varying the focal point in the sample in synchronism with longitudinal scanning of the sample.

“Method and Apparatus for Performing Optical Measurements” Issued US Patent 5,459,570, Oct. 14, 1995. Filed 3/16/93.

“Method and Apparatus for Performing Optical Imaging and Measurements” Issued in Europe and Japan.

“Method and Apparatus for Acquiring Images using a CCD Detector Array and No Transverse Scanner” Issued US Patent 5,465,147, Nov. 7, 1995. Filed 6/2/94. CIP of 4/29/91 filing.

“Method and Apparatus for Performing Optical Measurements using a Fiber Optic Imaging Guidewire, Catheter or Endoscope” Issued US Patent 6,134,003, Oct. 17, 2000. Filed 2/27/96.

“Methods and Apparatus for Forward-Directed Optical Scanning Instruments for the Acquisition of Optical Imaging and Delivery of Optical Radiation,” Pending Patent.

“Grating Based Phase Control Optical Delay Line” Issued US Patent 6,111,645 August, 2000.

“Method and Apparatus for Performing Optical Measurements using a Rapidly Frequency Tuned Laser” Issued US Patent 5,956,355 September 21, 1999.

“Short Coherence Length, Doppler Velocimetry System” Issued US Patent 5,501,226, 3/26/96. Filed 10/16/94. Issued EPO and Japan.

“Short Coherence Length, Doppler Velocimetry System” Issued US Patent 5,549,114, 8/27/96. Filed 10/23/95. Issued EPO and Japan.

“Optical Coherence Tomography Assisted Surgical Apparatus” Issued US Patent 6,004,314 December 21, 1999.

“OCT-Assisted Surgical Microscope with Multi- Coordinate Manipulator” Issued US Patent 5,795,295.

“Optical Coherence Tomography with New Interferometer” Issued US Patent 6,053,613.

“Method and Apparatus for Simultaneous Measuring the Length and Refractive Error of and Eye” Issued US Patent 5,975,699.

Measurement of Lens Characteristics” Issued US Patent 5,469,261 11/21/95.

“Fundus Illumination Apparatus Formed from Three Separated Radiation Path Systems” Issued US Patent 5,506,634, 4/9/96.

“Optical Coherence Tomography Corneal Mapping Apparatus” Issued US Patent 5,491,524, 2/13/96. Filed 10/5/94.

“Method and Apparatus for Optical Coherence Tomographic Fundus Imaging” Pending Patent.

“Gaze Tracking using Optical Coherence Tomography” Issued US Patent 5,644,642, 7/1/97. Filed 4/3/95.

“Optical Coherence Tomography Assisted Ophthalmologic Surgical Microscope” Issued US Patent 5,493,109, 2/20/96. Filed 8/18/94.

“Method and Apparatus for Optical Coherence Tomographic Fundus Imaging without Vignetting” Issued US Patent 5,537,162, 6/16/96. Filed 12/17/93.

“Method and Apparatus for High Speed Longitudinal Scanning in Imaging Systems” Issued US Patent 6,191,862 2/20/01.

“Fiber Optic Needle Probes for Optical Coherence Tomography Imaging” Patent Pending.

“Micro-Lens for Miniature Optical Probes” Patent Pending.

“Method and Apparatus for Performing Optical Frequency Domain Reflectometry” Issued US Patent 6,160,826. 12/12/00. Filed 1999.

“Broadband Light Source System and Method Thereof” Patent Pending.

“Apparatus and Method for Selective Data Collection and Signal to Noise Ratio Enhancement Using Optical Coherence Tomography” Patent Pending Filed 4/6/01.

“Fiber Optic Endoscopic Gastrointestinal Probe” Patent Pending.

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.